The top dose produced 20.9% average weight loss over 72 weeks and 20.2% in a direct comparison with semaglutides 13.7%. Its second receptor, GIP, separates tirzepatide from approved single-receptor GLP-1 drugs and helps explain the larger population-level weight loss. That 20.9% came from participants averaging about 105 kg at a BMI of 38, most of whom were sedentary
Fasting, zone 2 exercise, and proper sleep can naturally enhance growth hormone during off cycles
Danish and international guidelines state treatment goals for patients with T2D should be individualized, and because treatment guidelines suggest target ranges of HbA1c for different treatment goals, modelling treatment intensification varies between studies
Dehydration from gastrointestinal side effects such as nausea, vomiting, or diarrhea can contribute to feeling drained and physically depleted
This is the gold standard for tirzepatide users who want a drink